Scroll To Top
Search by Speciality

11th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease

Hilton Hotel Universal City * | Los angeles, USA
From 50 to 595 USD
Event Preview
This event
is Finished
Title: 11th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
Specialty: , Cardiology, Endocrinology, Gastroenterology, Other Specialties
Dates: From Nov, 7, 2013 to Nov, 9, 2013
Location: Los angeles, USA
Type: Congress
Registration Cost: From 50 to 595 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Los Angeles, Usa.
General Info
Event Venue:

Hilton Hotel Universal City *

Los Angeles, USA Visit the Venue to read more
Event Overview
Welcome message:

11th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
Exploring new frontiers in metabolism - Tomorrow's clinical science today!

November 7-9, 2013
Hilton Universal City Hotel, Los Angeles, CA

The World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) is a unique and exciting multidisciplinary program, to be held this year in Los Angeles, California. The Congress is the premiere global meeting dedicated to obesity, diabetes, metabolism and energy balance, linking research to clinical practice, and highlighting our theme -- exploring new frontiers in metabolism -- tomorrow's clinical science today. 

Since its inception, the Congress has become a home to clinical and basic scientists, researchers and practicing clinicians. The distinguished global faculty, combined with the Congress’ unique bench-to-bedside approach, has culminated in a state-of-the-art program. The expert and creative faculty promotes a new understanding of metabolic diseases; facilitates the development of future therapeutic modalities; and has been the cornerstone of the success of the Congress.

In recent years, there has evolved significant awareness of the contribution of multiple systems to energy metabolism, obesity, lipids, diabetes, and cardiovascular disease (CVD); notably incretins, gut hormones, and the brain. Dr. Gerald Reaven’s pioneering work crystallized the relationship of insulin resistance to these conditions, and various cancers. Of particular interest is the complicated interrelationship of nutrients, the gut, fat cell, insulin, leptin, and their respective resistance states, along with circadian rhythm, sleep disturbances, and the neuroendocrine system. The WCIRDC has become a distinguished platform where the interaction of these multiple metabolic systems is evaluated in a clinical, multidisciplinary environment.  Ultimately the Congress focuses on innovative approaches to developing a comprehensive plan for managing risk factors and diseases, which include lifestyle and medications. 

This year will heavily focus on and emphasize the complications of diabetes, and their increasing implications for clinical practice.  The Congress will introduce new aspects of obesity management, dyslipidemia as well as new aspects of bone, fat, leptin, adiponectin, mitochondria, and related proteins, to metabolic impairment in human disease.

There will be more workshops to help physicians better understand how to manage obesity, lipids, diabetes & the heart, and diabetes & cancer. All sessions will be followed by a panel discussion, and a clinical implications commentary by recognized experts.


Speakers 2013:

Yehuda Handelsman MD FACP, FACE, FNLA

Medical Director Principal investigator

Metabolic Institute of America

Chair, ICIR

Tarzana, California                           



Zachary T. Bloomgarden, MD

Clinical Professor of Medicine

Mount Sinai School of Medicine

Assistant Attending in Medicine

Mount Sinai Hospital

Consultant in Endocrinology

Lawrence Hospital

New York, New York


Nathan M. Bass, MBChB, PhD, FACP (MD)

Professor of Medicine Emeritus ,

University of San Francisco , CA


David S. Boyer, MD

Clinical Professor of Ophthalmology

University of Southern California

Keck School of Medicine

Senior Partner

Retina Vitreous Associated Medical Group

Los Angeles, California



Sonia Caprio, MD

Professor of Pediatric Endocrinology

Yale University School of Medicine

New Haven, Connecticut



Robert J. Chilton, DO, FACC

Professor of Medicine

Department of Medicine

Division of Cardiology

The University of Texas

Health Science Center

San Antonio, Texas



Rhoda H. Cobin, MD, MACE

Clinical Professor of Medicine

Mount Sinai School of Medicine

Past President ,AACE & ACE

New York, New York



Jaime A. Davidson, MD, FACP, MACE

Clinical Professor of Medicine

Division of Endocrinology

Diabetes and Metabolism 

Touchstone Diabetes Research Center

The University of Texas

Southwestern Medical Center

Dallas, Texas


Michael H. Davidson, MD

Clinical Professor

Director of the Lipid Clinic

The University of Chicago

Pritzker School of Medicine

Chicago, Illinois


Ralph A. DeFronzo, MD

Professor of Medicine

Chief, Diabetes Division

University of Texas

Health Science Center

Deputy Director

Texas Diabetes Institute

San Antonio, Texas


Andrew J. Drexler, M.D.

Professor of Medicine

Co-Chief, Division of Clinical Endocrinology,

Diabetes and Hypertension

Director, Gonda (Goldschmied) Diabetes Center

Los Angeles, California



Daniel Einhorn, MD, FACP, FACE

Clinical Professor of Medicine

Diabetes and Endocrine Associates

Medical Director, Scripps Whittier

Institute for Diabetes

San Diego, California


Ronald M. Evans, PhD

Professor, The Salk Institute

Investigator, Howard Hughes Medical Institute

March of Dimes Chair in Molecular

and Developmental Biology

San Diego, California


Ariel E. Feldstein, MD

Professor of  Pediatrics

Chief, Division of pediatrics, Gastroenterology

Hepatology and Nutrition

University of California, San Diego, California


Alan J. Garber, MD, PhD, FACE


Departments of Medicine,

Biochemistry & Molecular Biology

and Molecular and Cellular Biology

Baylor College of Medicine

Department of Medicine

Division of Diabetes, Endocrinology and Metabolism

Houston, Texas


George Grunberger, MD, FACP, FACE

Clinical Professor, Department of Internal Medicine

Center for Molecular Medicine & Genetics,

Wayne State University School of Medicine

Professor, Oakland University

William Beaumont Medical School

Bloomfield Hills, Michigan



W. Timothy Garvey, MD

Butterworth Professor and Chair

Department of Nutrition Sciences

GRECC Investigator and staff physician

Birmingham VA Medical Center

Director, UAB Diabetes Research and Training Center

Birmingham.  Alabama


Phillip Gorden, M.D.

Director Emeritus & Senior Investigator

National Institutes of Diabetes

Digestive and Kidney Disease

National Institutes of Health

Bethesda, Maryland



Peter J. Grant, MD, FMedSci

Professor of Medicine and Consultant Physician

Leeds Acute Trust, LIGHT Laboratories,

University of Leeds

Leeds, United Kingdom



Paul S. Jellinger, MD, MACE

Clinical Professor of Medicine,

Voluntary Faculty

University of Miami

The Center for Diabetes &

Endocrine Care

Past President, AACE & ACE

Hollywood, Florida


Ishwarlal (Kenny) Jialal, MD, PhD

Professor of Medicine

Division of Endocrinology, Diabetes and Metabolism

Robert E. Stowell Endowed Chair in Experimental Pathology

Director of the Laboratory for Atherosclerosis and Metabolic Research,

Director, Special Chemistry and Toxicology.

UC Davis, California



Samuel Klein, MD

Professor of Medicine & 

Nutritional Science William H. Danforth 

Director, Center for Human Nutrition

Chief, Division of Geriatrics &

Nutritional Science

Washington University

School of Medicine

St Louis, Missouri



Philip Levy, MD, MACE

Clinical Professor of Medicine

University of Arizona College of Medicine

Phoenix Endocrinology Clinics, Ltd.

Past President ACE

Phoenix, Arizona


Gary F. Lewis, MD

Professor, Departments of Medicine & Physiology

Director, Banting & Best Diabetes Center

Director, Division of Endocrinology & Metabolism

University of Toronto

Toronto, On, Canada



Ronald M. Krauss, MD

Director, Atherosclerosis Research Children’s Hospital Oakland

Senior Scientist, Genome Sciences Division Lawrence Berkeley

National Laboratory University of California

Berkeley, California


Clifford J. Rosen MD

Professor of Medicine,

Tufts University School of Medicine

Director of Clinical and Translational Research,

Maine Medical Center Research Institute

Boston Massachusetts



Alan R. Sinaiko, MD

Professor, Department of Pediatrics

Division of Nephrology

University of Minnesota

Medical School Pediatric Nephrology

Minneapolis, Minnesota


Alan S. Maisel, MD

Professor of Medicine

Director Coronary Care Unit and Heart Failure program

Veterans Affairs San Diego Healthcare System

San Diego, California



Nikolaus Marx, MD, FAHA

Professor of Medicine / Cardiology

Head of the Department of Internal Medicine

University Hospital Aachen

Aachen, Germany


Darren K. McGuire, MD, MHSc, FAHA, FACC

Professor of Internal Medicine

Dallas Heart Ball Chair For

Research on Heart Disease in Woman

University of Texas Southwestern Medical Center

Dallas, Texas



Tracey L. McLaughlin, MD, MS

Assistant Professor of Medicine

Division of Endocrinology,

Gerontology and Metabolism

Stanford Medical Center

Stanford, California


Marc R. Montminy, MD PhD 

Professor of Medicine

Clayton Foundation Laboratories for Peptide Biology 

J.W. Kieckhefer Foundation Chair

The Salk Institute for Biological Studies

La Jolla, California 


NING Guang, MD, Ph.D. 

Professor of medicine

Principal Investigator

Laboratory of Endocrine & Metabolic Diseases

The Institute of Health Sciences

Shanghai , China


Walter J. Pories, MD, FACS

Professor of Surgery, Biochemistry

Exercise and Sport Science

Director, Bariatric Surgery Research 

Division of Advanced Laparoscopic,

Gastrointestinal and Endocrine Surgery

Brody School of Medicine

East Carolina University

Greenville, North Carolina


Michael W. Schwartz, MD

Robert H. Williams Endowed Chair in Medicine

Director, Diabetes and Obesity Center of Excellence

Director, UW Nutrition Obesity Research Center

Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition

University of Washington


Reuben J. Shaw, PhD

Associate Professor

Howard Hughes Medical Institute

Molecular and Cell Biology Laboratory

The Salk Institute for Biological Studies

La Jolla, Califronia 



Bart Staels, PhD  

Full Professor, University of Lille

Nord de France

Head of Inserm

Lille, France


Gerald M. Reaven, MD

Professor of Medicine (Active Emeritus)

Division of Cardiovascular Medicine

Stanford University

School of Medicine

Stanford, California



Jorge Plutzky, MD

Director, The Vascular Disease

Prevention Program Cardiovascular Division

Brigham and Women’s Hospital

Harvard Medical School

Boston,  Massachusetts


Paul D. Rosenblit, MD , PhD FACE, FNLA

Clinical Professor of Medicine

Division of Endocrinology Diabetes & Metabolism

University of California Irvine School of Medicine

Co Director Diabetes

Out Patient Clinic Director

Diabetes Lipid Management & Research Center

Irvine, California


Allan Sniderman, MD

Professor of Medicine

McGill University.

Director of the Mike Rosenbloom Laboratory for

Cardiovascular Research

Royal Victoria Hospital in

Montreal, Canada


Registration Not yet available Register Now

The 11th Annual World Congress on Insulin Resistance, Diabetes & CVD (WCIRDC) will be held at the prestigious 


Hilton Universal City Hotel

555 Universal Hollywood Drive, Universal City, California 91608-1001

The Hilton Universal

For reservations please call: 818-506-2500 or reserve a room online.


We have reserved rooms for conference participants and their guests at the special rate of $165.


Prices are subject to current state, local, and occupancy tax.


Rooms will be available on a first-come basis, and will be available until all are filled, or until the cut-off date of October 7, 2013.


Group room rates will be available three (3) days prior to and three (3) days after the event date.


Please mention the Group Name: WCIRDC and Group Code: WCIR


If you need special accommodations or have questions about access to any of our activities, please contact the meeting organizers at:
818-342-1889 or


Scientific Content Up to Date
Submission Info

Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease.  Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.   

The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level.

To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.

  1. Scientific materials presented at the 11th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease must not have been published or presented prior to November 7, 2013, other than in abstract form.
  2. All abstracts must be filed electronically and emailed to us ( ), as a Microsoft Word document of no more than 250 words saved as .RTF (Rich Text Format). Submissions will not be accepted by fax or mail.  
  3. Authorship on multiple abstracts is permitted.
  4. All materials must arrive on or before the abstract deadline noted above.
  5. All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
  6. Abstracts may be submitted for poster presentation. If selected for poster presentation, the author is required to register for the Congress and to be present during the poster sessions. Awards will be given for the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mention. The authors of the winning abstracts will orally present their research findings during the Plenary Sessions in a ten minute presentation, to be followed by a five minute period of discussion.
  7. If selected for oral presentation, an author is required to register for the Congress and to be prepared for the oral presentation with a PowerPoint presentation.  Abstracts must be accompanied by a statement from the authors agreeing that, if chosen, they will prepare a poster presentation, and that, if awarded a high ranking, they will prepare an oral presentation.
  8. Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.   
  9. Abstracts will be published in: Endocrine Practice.
    Editor-in-Chief – Dr. Lewis E. Braverman
    “Endocrine Practice is a peer-reviewed journal published six times a year, and is the official journal of the American College of Endocrinology (ACE) and the American Association of Clinical Endocrinologists (AACE). The first issue of Endocrine Practice was published in 1995. The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.”    
Sponsors Exhibitors
Organising Agency

18372 Clark Street Suite 212
Tarzana, CA 91356

Phone: 818-342-1889
Fax    : 818-342-1538

Official Event Webpage
Event map
Revelant Events